Jonathan Meyer Email & Phone Number

Austin, Tx, Us

Philadelphia, Pennsylvania, Us

Tarrytown, New York, Us

Cambridge, Massachusetts, Us

- Supported the BEACON study to investigate the effects of BEAM-101, a gene edited, autologous HSCT for the treatment of severe SCD

Tarrytown, New York, Us

- Supported CRISPR/Cas9-based Factor 9 gene insertion program for hemophilia B- Supported first-in-human and clinical experimental science studies in the cardiovascular and metabolic space- Supported initiatives to assess the cardiovascular portfolio from target nomination through post-IPA (drug nomination)- Supported both early-and late-phase studies of REGN-COV2 (REGEN-COV, Ronapreve), an investigational anti-SARS-CoV-2 antibody combo, for the prevention and treatment of COVID-19

Tarrytown, New York, Us

Baltimore, Md, Us

- Served as preceptor for 8 students who were interested in careers in the pharmaceutical industry- Assessed student performance and provided feedback on both deliverables and professional presence- Taught students about the role of a clinical development scientist

Cambridge, Cambridgeshire, Gb

- Supported a Phase 2b study (REAL-TIMI 63b) in collaboration with with the TIMI Study Group of a product (MEDI6012) for use in STEMI- Supported a Ph1 study of another product (MEDI6570) for secondary prevention post-myocardial infarction (MI)- Developed and reviewed regulatory documents including investigator brochures (IBs), protocols, clinical narratives for clinical study reports (CSRs), development safety update reports (DSURs)- Medical monitoring of patients on trials- Data review and reconciliation (using JReview and Medidata RAVE)- Good clinical practice (GCP) training- Developed and reviewed electronic Case Report Forms (eCRFs), statistical analysis and programming plans (SAPs and SPPs), dose escalation committee (DEC) documents, and study charters- Organized and participated in site initiation visits (SIVs), investigator meetings, safety review team (SRT) meetings- Assessed protocol deviations- Reviewed proposals for selection of CRO

Cambridge, Cambridgeshire, Gb

- Supported development of oncology assets including antibody-drug conjugate (ADC) and immuno-oncology (IO) products (MEDI3726 and MEDI9447, respectively)- Developed and reviewed regulatory documents including investigator brochures (IBs), protocols, clinical narratives for clinical study reports (CSRs), development safety update reports (DSURs)- Medical monitoring of patients on trials- Data review and reconciliation (using JReview and Medidata RAVE)- Good clinical practice (GCP) training- Developed and reviewed electronic Case Report Forms (eCRFs), statistical analysis and programming plans (SAPs and SPPs), dose escalation committee (DEC) documents, and study charters- Organized and participated in site initiation visits (SIVs), investigator meetings, safety review team (SRT) meetings- Assessed protocol deviations- Reviewed proposals for selection of CRO

Los Angeles, Ca, Us

- Managed $10M in grants and purchased necessary equipment and reagents for a lab of over 25 researchers- Supervised our mouse colony to ensure that the mice were healthy and that animal care regulations were strictly enforced- Investigated the role of viral interferon regulatory factor 4 (vIRF-4) in KSHV infected cells- Designed and cloned various plasmid constructs necessary for experiments- Worked in aseptic conditions for culturing 293T and BCBL cells- Performed immunoprecipitation and yeast two-hybrid experiments to detect protein-protein interactions

Doctor Of Pharmacy (Pharm.D.), Pharmacy

B.S., Biochemistry, Musical Studies (Clarinet Performance) Minor